MARENDA RUSSELL: Open Payments
NPI 1245700731 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,173 in 65 payments from 20 companies in 2025. Trend: 2023 $1,128 · 2024 $1,128 · 2025 $3,173
Food & beverage: $1,622Travel & lodging: $1,551
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 14 | $2,188 |
| Novartis Pharmaceuticals Corporation | 9 | $198 |
| SCPHARMACEUTICALS INC. | 12 | $160 |
| CVRx, Inc. | 2 | $117 |
| Merck Sharp & Dohme LLC | 3 | $62 |
| BridgeBio Pharma, Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| PFIZER INC. | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Amgen Inc. | 2 | $39 |
Products named: CARDIOMEMS, FUROSCIX, LEQVIO, Barostim Neo System, VERQUVO, Attruby, VYNDAQEL, JARDIANCE.
Industry payments across GA — which companies pay providers there.
